Aurora Cannabis Inc. Announces Filing and Mailing of Management Information Circular in Connection with Upcoming Annual General and Special Meeting of Shareholders
NASDAQ | TSX: ACB
-
Your vote is important no matter how many shares you own. Please vote today.
-
Shareholders with questions or who need assistance voting their shares
should contact Aurora's strategic advisor and proxy solicitation agent,
Laurel Hill Advisory Group (Toll-Free Tel: 1-877-452-7184 / International Tel: 1-416-304-0211/ E-mail: assistance@laurelhill.com )
Shareholder Meeting Details
The Meeting will be held virtually on
At the Meeting, shareholders will be asked to vote on matters that are crucial for the Company as we continue into our next stage of global growth. Great strides have been made over the past few years to stabilize the Company, strengthen our balance sheet and reduce our debt balance. With a strong focus on pursuing profitable growth, Aurora has weathered much of the challenges that most in the cannabis industry have and continue to face. In fact, fiscal 2024 was the Company's strongest year to date.
Our ability to continue to build value in your investment requires stability, certainty and continued execution against our stated objectives. Aurora's Board of Directors (the "Board") and management remain focused on achieving positive free cash flow by the end of calendar 2024 and we are confident that we have in place the talent and expertise on our Board and management team to achieve this and to deliver industry-leading performance and shareholder value. We are excited to share our story and to give our shareholders confidence in the future of the Company – which we believe is incredibly bright.
We invite all shareholders to view this message from Aurora CEO
The Board recommends that shareholders vote FOR all of the director nominees and meeting resolutions.
Shareholders are encouraged to read the Circular and vote as soon as possible. The deadline for voting your shares is
YOUR VOTE IS IMPORTANT - VOTE YOUR SHARES FOR AURORA'S DIRECTOR NOMINEES AND MEETING RESOLUTIONS AS SOON AS POSSIBLE
Shareholder Questions
Shareholders who have any questions or require assistance with voting may contact the Aurora's proxy solicitation agent and shareholder communications advisor:
Toll Free: 1-877-452-7184 (for shareholders in
International: +1 416-304-0211 (for shareholders outside
By Email: assistance@laurelhill.com
About Aurora
Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and South America. Headquartered in Edmonton,
Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB".
Forward Looking Statements
This news release includes statements containing certain "forward looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include statements regarding the Meeting and the future success of the Company, including the path and timing to achieve positive free cash flow and shareholder value creation.
These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and nongovernment consumer sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration of acquired business and operations, management's estimation that SG&A will grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises, and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information form dated June 20, 2024 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR at www.sedarplus.com and filed with and available on the
View original content to download multimedia:https://www.prnewswire.com/news-releases/aurora-cannabis-inc-announces-filing-and-mailing-of-management-information-circular-in-connection-with-upcoming-annual-general-and-special-meeting-of-shareholders-302191689.html
SOURCE